Navigation Links
Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge
Date:6/26/2008

patent infringement cases; the outcome of litigation arising from challenging the validity or non-infringement of patents covering our products; the difficulty of predicting the timing of FDA approvals; court and FDA decisions on exclusivity periods; the ability of competitors to extend exclusivity periods for their products; our ability to complete product development activities in the timeframes and for the costs we expect; market and customer acceptance and demand for our pharmaceutical products; our dependence on revenues from significant customers; reimbursement policies of third party payors; our dependence on revenues from significant products; the use of estimates in the preparation of our financial statements and our forecasts; the impact of competitive products and pricing on products, including the launch of authorized generics; the ability to launch new products in the timeframes we expect; the availability of raw materials; the availability of any product we purchase and sell as a distributor; the regulatory environment in the markets where we operate; our exposure to product liability and other lawsuits and contingencies; the increasing cost of insurance and the availability of product liability insurance coverage; our timely and successful completion of strategic initiatives, including integrating companies (such as PLIVA d.d.) and products we acquire and implementing our new SAP enterprise resource planning system; fluctuations in operating results, including the effects on such results from spending for research and development, sales and marketing activities and patent challenge activities; the inherent uncertainty associated with financial projections; our expansion into international markets through our PLIVA acquisition, and the resulting currency, governmental, regulatory and other risks involved with international operations; our ability to service our significantly increased debt obligations as a result of the PLIVA acquisition; changes in ge
'/>"/>
SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6
2. ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0
3. Wyeth Pharmaceuticals Announces Organizational Change
4. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
5. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
6. Cell Biosciences Announces New Leadership
7. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
8. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
9. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
10. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
11. Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 Genes in Space, a nation-wide ... landing at New England Biolabs® (NEB®) along with ... scientific exploration and celebration, on Thursday, July 9 ... Boeing®, The Center for Advancement of Science in ... to design an experiment to solve a real-life ...
(Date:7/7/2015)... ... July 07, 2015 , ... bioLytical Laboratories Inc. announced ... was accepted for presentation at the 8th Annual International AIDS Society (IAS) Conference ... Wednesday, July 22nd from 1:00 pm to 2:00pm Pacific Standard Time at the ...
(Date:7/7/2015)... 2015   Moleculera Labs today announced ... from the Oklahoma Center for the Advancement of ... development and clinical validation of new diagnostic testing ... in patients experiencing neuropsychiatric disorders such as depression, ... to assist physicians in identifying the subset of ...
(Date:7/7/2015)... , ... July 07, 2015 , ... CSM, a leading ... as Vice President of Finance. Morse has an extensive background in financial management and ... the CSM team. In his new role, Morse will oversee all financial areas of ...
Breaking Biology Technology:Genes in Space finalists attend laboratory workshop and celebration at New England Biolabs' headquarters 2bioLytical to Present Findings of Early HIV Detection 2bioLytical to Present Findings of Early HIV Detection 3Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3CSM Appoints Michael Morse as Vice President of Finance 2
... Calif., April 28 Telik, Inc. (Nasdaq: TELK ) ... that were presented at the 100th annual meeting of the American ... can be found on the Telik website, www.telik.com ... Action of Orally Active Aurora Kinase/ VEGFR Inhibitors; Abstract # 1764 ...
... Pa., April 28 Particle Sciences, Inc. today announced ... Director, Quality Assurance. Mr. Garcia will report to ... Sciences following more than 30 years experience in pharmaceutical ... Wyeth as Senior Director of Quality Operations. Prior ...
... More listings for life science postgraduates than any other ... Career Center has become the nation,s number one jobs ... board, www.biocareercenter.com , is only for ... with 19 of the most prestigious universities in the ...
Cached Biology Technology:Telik Reports Preclinical Results at AACR Annual Meeting 2Telik Reports Preclinical Results at AACR Annual Meeting 3Hector Garcia Joins Particle Sciences as Director of Quality Assurance 2Bio Career Center Becomes Top in Nation for Life Sciences Careers 2
(Date:6/17/2015)... Calif. , June 17, 2015  Synaptics ... human interface solutions, today announced that Xiaomi, one ... the Synaptics ® ClearPad ® family ... display driver integrated circuits (DDICs) for its latest ... By leveraging ClearPad for full in-cell display solutions ...
(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - ... partnership centralized around the incorporation of handyem,s HPC-150 ... diagnostic laboratory, the Mo-POD™. This unprecedented model of ... International Conference at the Pennsylvania ... from June 15 th to 18 th ...
(Date:6/16/2015)... Fingerprint Cards has received an order ... company,s portfolio from one of its module partners in ... place during the third quarter 2015. The sensors will be ... Jörgen Lantto, CEO of FPC, comments: " This ... interest from smartphone OEMs in integrating touch fingerprint sensors in ...
Breaking Biology News(10 mins):Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2
... research has found that if you want some of the ... vegetables, you need to eat the real thing a ... far less value if taken as a supplement. The ... Oregon State University, is one of the first of its ...
... down shortly after an asteroid plowed into the Gulf of ... to widespread global extinctions including the demise of big dinosaurs, ... to show themselves following the global catastrophe. While ... on the survival and proliferation of mammals, paleo-botanical studies show ...
... Mich.---It,s "Waterworld" snail style: Ocean-dwelling snails that spend most ... of mucus bubbles. Scientists have known about ... wondered how the rafting habit evolved. What, exactly, were ... Michigan graduate student Celia Churchill and coauthors believe they,ve ...
Cached Biology News:Health benefits of broccoli require the whole food, not supplements 2Health benefits of broccoli require the whole food, not supplements 3Worms among first animals to surface after K-T extinction event, CU-led study finds 2Worms among first animals to surface after K-T extinction event, CU-led study finds 3In bubble-rafting snails, the eggs came first 2In bubble-rafting snails, the eggs came first 3In bubble-rafting snails, the eggs came first 4
... acid , DTNB , Ellman's reagent ... *CAS-No.: 69-78-3 *Storage: RT, When ... reactive grouping not present in the substrate, it ... will react directly with the product to form ...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
... SUPERaseIn RNase Inhibitor (patent pending) is a ... noncovalently binds and inhibits the most common ... C, 1 and T1. SUPERaseIn can be ... could be problematic. It is ideal for ...
... Inhibitor is a potent noncompetitive ... as RNase A. Like other ... Inhibitor is an acidic protein ... kDa. RNaseOUT inhibits RNase A ...
Biology Products: